Necrotizing Enterocolitis News and Research

RSS
Necrotizing enterocolitis (NEC) is a life-threatening condition that manifests as inflammation of the intestines. This devastating disease affects mostly premature babies, who account for up to 8 out of every 10 cases. In NEC, bacteria invade the intestinal wall. The resulting local infection and inflammation lead to the destruction of the intestinal lining, even through its entire thickness.
Researchers find main cause of necrotizing enterocolitis-related lung damage in preemies

Researchers find main cause of necrotizing enterocolitis-related lung damage in preemies

Acid suppression drugs frequently prescribed for high-risk newborns, study shows

Acid suppression drugs frequently prescribed for high-risk newborns, study shows

Researchers reveal link between necrotizing enterocolitis and uropathogenic E. coli

Researchers reveal link between necrotizing enterocolitis and uropathogenic E. coli

Gut microbial imbalance appears to be underlying cause of fatal intestinal illness in premature babies

Gut microbial imbalance appears to be underlying cause of fatal intestinal illness in premature babies

Severe anemia associated with increased risk for necrotizing enterocolitis in premature infants

Severe anemia associated with increased risk for necrotizing enterocolitis in premature infants

Large doses of vitamin A reduce severity of gastrointestinal disease in mice

Large doses of vitamin A reduce severity of gastrointestinal disease in mice

Presence of blood eosinophilia during NEC predicts life-threatening complications for preemies

Presence of blood eosinophilia during NEC predicts life-threatening complications for preemies

Study reveals benefit of early screening for vascular disorder patent ductus arteriosus among preterm infants

Study reveals benefit of early screening for vascular disorder patent ductus arteriosus among preterm infants

JAMA: Extremely preterm infants enrolled in randomized clinical trials experience neither better nor worse outcomes

JAMA: Extremely preterm infants enrolled in randomized clinical trials experience neither better nor worse outcomes

Nutrinia's NTRA-9620 granted FDA orphan drug designation for treatment of short bowel syndrome

Nutrinia's NTRA-9620 granted FDA orphan drug designation for treatment of short bowel syndrome

Lactobacillus reuteri may reduce risk of necrotizing enterocolitis in premature infants

Lactobacillus reuteri may reduce risk of necrotizing enterocolitis in premature infants

Scientists reveal how breast milk prevents necrotizing enterocolitis in premature babies

Scientists reveal how breast milk prevents necrotizing enterocolitis in premature babies

New standardized approach for feeding infants in NICU improves growth of babies

New standardized approach for feeding infants in NICU improves growth of babies

Eight clinical researchers selected as finalists for Outstanding Investigator Award at Cardiology 2015

Eight clinical researchers selected as finalists for Outstanding Investigator Award at Cardiology 2015

Researchers to present report on impact of fetal gender on preterm birth risk at The Pregnancy Meeting

Researchers to present report on impact of fetal gender on preterm birth risk at The Pregnancy Meeting

CHLA scientists grow tissue-engineered small intestine from human cells

CHLA scientists grow tissue-engineered small intestine from human cells

Children who require long-term parenteral nutrition are at risk of IAFLD

Children who require long-term parenteral nutrition are at risk of IAFLD

Growth factors present in human breast milk may protect against intestinal damage

Growth factors present in human breast milk may protect against intestinal damage

Breast milk may protect premature infants from intestinal destruction

Breast milk may protect premature infants from intestinal destruction

Human milk diet protects intestines and supports growth of premature infants

Human milk diet protects intestines and supports growth of premature infants